Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2014
03/26/2014CN103687867A Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
03/26/2014CN103667321A Protein preparation method for improving immune effect of M2 pyruvate kinase
03/26/2014CN103667106A Lactobacillus plantarum, bacteriocins and culture, separation and purification method thereof
03/26/2014CN103665133A Alpha-conotoxin peptide LvIA/LvD21, and pharmaceutical composition and use thereof
03/26/2014CN103665130A Alpha-conotoxin peptide TxIC/Txd1 and medicinal composition and application thereof
03/26/2014CN103665115A Chemical preparation method of cyclic decapeptide compound GG-110824
03/26/2014CN103665114A Peptide and preparation method and use thereof, and pharmaceutical composition and preparation method of pharmaceutical composition
03/26/2014CN103665113A Human A beta 42 antigenic determinant polypeptide, human A beta 42 antigen, human A beta 42 antibody, application and kit
03/26/2014CN103665112A Novel antivirus polypeptide, and preparation method and application thereof
03/26/2014CN103665111A Transformed body HC-15 of antimicrobial peptide Hc-CATH (cathelicidins) of hydrophis cyanocinctus and preparation method and application of transformed body
03/26/2014CN103665110A Half-path charge complementary type chiral self-assembled short-peptide nanometer biomedical material and application
03/26/2014CN103665109A Synthesis method of C-terminal pentapeptide of osteogenic growth peptide
03/26/2014CN103665108A Preparation methods and application of streptomyces parvulus OUCMDZ-2554 bacterial strain and product actinomycin D thereof
03/26/2014CN103665107A Novel compound combining functions of dissolving thrombus, scavenging free radicals and targeting thrombus, as well as preparation method and application thereof
03/26/2014CN103665106A Antineoplastic polypeptide and preparation method and applications thereof
03/26/2014CN103665105A Pristinamycin IA crystal
03/26/2014CN103665104A Method for synthesizing MMAF (Monomethyl Auristantin F) intermediate pentapeptide
03/26/2014CN103664434A Method for preparing disulfide and generating hydrogen gas based on quantum dot catalysis
03/26/2014CN103145801B Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MTA1 (Tumor Metastasis Associated Antigen 1) and application thereof
03/26/2014CN103059102B Polypeptide for inhibiting hepatitis C viruses (HCVs) from infecting cells, and its application
03/26/2014CN102965304B Daptomycin high-producing strain and preparation method thereof
03/26/2014CN102924577B Chicken high mobility group protein B1 (chHMGB1) antigen polypeptide and anti-chHMGB1 monoclonal antibody
03/26/2014CN102746377B Epitope peptide of mycobacterium trberculosis protein antigen, and its application
03/26/2014CN102603864B Synthesis and gel property of dendritic gel factor taking phenylalanine and glycine as construction units
03/26/2014CN102307893B Peptides for vaccine
03/26/2014CN101993477B Preparation method of deoxy analog of Echinocandin B
03/26/2014CN101965356B Polypeptide specifically bound to phosphatidylserine and the use thereof
03/25/2014US8680234 Polymyxin derivatives and uses thereof
03/25/2014US8680233 Heteropeptides useful for reducing nonspecific adsorption
03/25/2014US8680058 Selectively targeted antimicrobial peptides and the use thereof
03/25/2014US8680056 Antiproliferative factor and methods of use
03/25/2014US8680046 Inhibitors of viral integrase and methods of use
03/25/2014CA2607142C Personal care compositions and methods for their use
03/25/2014CA2434672C Sfrp and peptide motifs that interact with sfrp and methods of their use
03/20/2014WO2014042209A1 Peptides that bind to epithelial cell adhesion molecule
03/20/2014WO2014041111A1 Usp30 inhibitors and methods of use
03/20/2014WO2014040302A1 Use of pedf-derived polypeptides for treating alopecia and/or hair depigmentation
03/20/2014WO2014040178A1 Trpv3 agonists for the treatment of skin conditions
03/20/2014WO2014040158A1 (argo)n-angiotensin-(1-7) peptide and pharmaceutical compositions for treating diseases
03/20/2014WO2013023319A8 In vitro method for modification of the depletion profile of regulatory t cells present in a total population of splenocytes in a sample, culture and exposure of said cells to a medium with atp and polymyxin b
03/20/2014US20140080996 Skin or hair binding peptides
03/20/2014US20140080762 Hyd1 peptides for relapsed cancer
03/20/2014US20140080175 Processes for preparing tubulysin derivatives and conjugates thereof
03/20/2014US20140079753 Bmp binding peptides
03/20/2014US20140079701 Linker peptides and polypeptides comprising same
03/19/2014EP2708551A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
03/19/2014EP2708533A1 Preparation method of micafungin sodium
03/19/2014EP2707394A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
03/19/2014EP2707384A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
03/19/2014EP2707023A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
03/19/2014CN103649317A Therapeutic fusion proteins
03/19/2014CN103649108A A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
03/19/2014CN103649107A Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
03/19/2014CN103649106A Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
03/19/2014CN103642757A Bluetongue virus NS2 protein monoclonal antibody BTV-4D4, B cell epitope recognized thereby and applications
03/19/2014CN103641894A Preparation method of polypeptide medicine for treating cushing disease
03/19/2014CN103641893A Method for recovering colistin sulfate from colistin sulfate slag
03/19/2014CN103641892A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN103641891A Method for preparing Kahalalide F
03/19/2014CN103641890A Synthetic method of kyprolis
03/19/2014CN103641889A Hypoglycemic peptide and drug use thereof
03/19/2014CN103641888A Multifunctional novel small peptide, composition including same and application of small peptide
03/19/2014CN103638536A Molecular probe and preparation method and application thereof
03/19/2014CN103638514A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
03/19/2014CN102786583B Rana kunyuensis modified antibacterial peptides as well as preparation method and application of rana kunyuensis kunyuenin kunyuenin-3
03/19/2014CN102250218B Method for hydrogen-bonding adsorption purification of oxytocin by using agarose comprising beta-cyclodextrin ligand
03/18/2014US8674072 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
03/18/2014US8674069 MELK epitope peptides and vaccines containing the same
03/18/2014US8674062 Cell culture compositions
03/18/2014US8674061 Multiligand constructs
03/18/2014US8674060 Peptide ligand to impair cancer cell migration
03/18/2014US8674020 Process for preparing polyamides
03/18/2014US8673850 PCSK9 inhibitors and methods of use thereof
03/18/2014US8673849 Lactadherin-derived peptides as antiviral agents
03/18/2014US8673848 Synthetic apelin mimetics for the treatment of heart failure
03/18/2014US8673270 RGD-containing peptidomimetics and uses thereof
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2462713C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
03/13/2014WO2014039014A1 Peptides and their uses
03/13/2014WO2014039013A1 Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof
03/13/2014WO2014037977A1 Method for quantifying absolute mass of marker protein for individualized treatment and diagnosis
03/13/2014WO2014036971A1 Methods of using immunomodulating peptide for treating or preventing inflammatory related diseases
03/13/2014WO2014036821A1 Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
03/13/2014WO2013181339A3 Cyclosporin a analogs
03/13/2014WO2013013085A3 Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis
03/13/2014US20140073760 Use of an ang-(1-7) receptor agonist in acute lung injury
03/13/2014US20140073571 Treatments for Gastrointestinal Disorders
03/13/2014US20140073559 Antibiotic Compositions for the Treatment of Gram Negative Infections
03/13/2014US20140073558 Novel antibacterial agents for the treatment of gram positive infections
03/13/2014US20140073556 Antagonists of the Interleukin-1 Receptor
03/13/2014US20140072650 Gelatin extract made from skate ray skin and antihypertensive composition having peptide isolated from extract as active ingredient
03/13/2014US20140072574 Methods of using immunomodulating peptide for treating or preventing inflammatory related diseases
03/13/2014DE112011105133T5 Octapeptid zur Herstellung von radiopharmazeutischen Mitteln, das auf dessen Basis hergestellte Arzneimittel und Diagnoseverfahren von Somatostatin-Rezeptor exprimierenden Tumoren Octapeptide for the preparation of radiopharmaceutical agents, on the basis of the produced medicinal products and diagnostic methods of somatostatin receptor-expressing tumors
03/12/2014EP2705142A1 Synthetic composition and coating for cell culture.
03/12/2014CN103635806A Method of obtaining a binder to prepro-vasopressin or fragments thereof
03/12/2014CN103635204A CETP fragments
03/12/2014CN103630646A Method for detecting tortoise-derived ingredients in glue type traditional Chinese medicines and products thereof
03/12/2014CN103630644A LC-MS (Liquid Chromatography-Mass Spectrometry) detection method for tortoise-derived ingredients in glue type traditional Chinese medicines and products thereof
03/12/2014CN103630621A Method for detecting sheep-derived ingredients in glue type traditional Chinese medicines and products thereof
03/12/2014CN103626849A Method for preparing linaclotide
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 423